The synaptic organizers, ?-neurexins, form macromolecular bridges with their post-synaptic partners that span the synaptic cleft (?trans-synaptic bridges?); together they play a crucial role in mediating synaptic connections and communication between neurons. ?-Neurexins and their partners are implicated in neurological disorders including autism spectrum disorder, schizophrenia and mental retardation. ?-Neurexin trans-synaptic bridges have traditionally been considered static. However, there is accumulating evidence that they are in fact dynamically regulated! Dynamic regulation of ?-neurexin trans- synaptic bridges is important, because it means that the synapse-promoting role of ?-neurexins is tunable and can be increased or decreased at a particular synapse. Three very different mechanisms have recently been revealed that control the trans-synaptic bridges between ?-neurexins and their partners: 1) competing decoys, 2) proteins secreted by astrocytes, and 3) allosteric modulation of ?-neurexin binding partners. However, it is not known on a molecular level how these mechanisms work. It is essential to determine the molecular bases that underlie these regulatory mechanisms, because they not only control the synapse-promoting activity of ?-neurexins, but they also involve protein interactions that could be targeted to manipulate specific synaptic connectivities and exploited therapeutically. In this proposal, we will determine the molecular bases of three mechanisms that control the formation of ?-neurexin trans-synaptic bridges. We hypothesize that these different molecular mechanisms exploit unique elements in the 3D structure of ?-neurexins and their partners to generate platforms that permit dynamic regulation. We will use structural, biophysical and biochemical techniques to elucidate mechanisms involving 1) competing synaptic organizers, 2) astrocytic factors, and 3) allosteric modulation. Collectively, our results will reveal on a molecular level how regulatory mechanisms mold ?-neurexin trans-synaptic bridges impacting synapse development and synaptic communication. This proposal is significant because genetic lesions in ?-neurexins and their partners are involved in the pathogenesis of severe neurological disorders, so mechanisms regulating their interactions and functions, control their contribution to disease as well. This work will also set the stage for developing mechanism-based, focused therapies to address specific CNS disorders. This proposal is conceptually innovative because it will help establish the emerging paradigm shift that trans- synaptic bridges formed by synaptic organizers, like ?-neurexins and their partners, are in fact subject to intense regulation and their ability to stabilize synaptic function is rendered tunable by other interacting proteins. This proposal is also technically innovative because it involves single particle electron tomography for which we are actively developing methodologies to image synapse organizing molecules.

Public Health Relevance

The synaptic organizers, ?-neurexins, play a central role in severe neuropsychiatric diseases including autism spectrum disorder and schizophrenia. ?-Neurexins in conjunction with their partners form trans-synaptic bridges that are dynamically regulated. Elucidating the molecular basis of these regulatory mechanisms will reveal how they impact synapse development and contribute to the plasticity of neural circuits; it will also lay the foundation to investigate highly innovative, mechanism-based therapies that target excitatory versus inhibitory synapse development, respectively, to ameliorate specific CNS disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH077303-14
Application #
9910228
Study Section
Synapses, Cytoskeleton and Trafficking Study Section (SYN)
Program Officer
Driscoll, Jamie
Project Start
2006-04-01
Project End
2023-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
14
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Med Br Galveston
Department
Pharmacology
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Liu, Jianfang; Misra, Anurag; Reddy, M V V V Sekhar et al. (2018) Structural Plasticity of Neurexin 1?: Implications for its Role as Synaptic Organizer. J Mol Biol 430:4325-4343
Gangwar, Shanti Pal; Zhong, Xiaoying; Seshadrinathan, Suchithra et al. (2017) Molecular Mechanism of MDGA1: Regulation of Neuroligin 2:Neurexin Trans-synaptic Bridges. Neuron 94:1132-1141.e4
Kim, M J; Biag, J; Fass, D M et al. (2017) Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity. Mol Psychiatry 22:417-429
Rudenko, Gabby (2017) Dynamic Control of Synaptic Adhesion and Organizing Molecules in Synaptic Plasticity. Neural Plast 2017:6526151
Lu, Zhuoyang; Reddy, M V V V Sekhar; Liu, Jianfang et al. (2016) Molecular Architecture of Contactin-associated Protein-like 2 (CNTNAP2) and Its Interaction with Contactin 2 (CNTN2). J Biol Chem 291:24133-24147
Meyer, Peter A; Socias, Stephanie; Key, Jason et al. (2016) Data publication with the structural biology data grid supports live analysis. Nat Commun 7:10882
Cates, Hannah M; Thibault, Mackenzie; Pfau, Madeline et al. (2014) Threonine 149 phosphorylation enhances ?FosB transcriptional activity to control psychomotor responses to cocaine. J Neurosci 34:11461-9
Lu, Zhuoyang; Wang, Yun; Chen, Fang et al. (2014) Calsyntenin-3 molecular architecture and interaction with neurexin 1?. J Biol Chem 289:34530-42
Pettem, Katherine L; Yokomaku, Daisaku; Luo, Lin et al. (2013) The specific *-neurexin interactor calsyntenin-3 promotes excitatory and inhibitory synapse development. Neuron 80:113-28
Chen, Fang; Venugopal, Vandavasi; Murray, Beverly et al. (2011) The structure of neurexin 1ýý reveals features promoting a role as synaptic organizer. Structure 19:779-89

Showing the most recent 10 out of 12 publications